Menu
Fechar
HRS4R
Vull donar
Firma
JESSICA LATORRE-LUQUE
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2
Projectes
Publicacions

Projectes

Nutrició, Eumetabolisme i Salut

Ayuda de personal Miquel Servet

Codi oficial: MS19/00109 Data inici: 01/01/2020 Data fi: 31/12/2024 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 202,500 €
Nutrició, Eumetabolisme i Salut

Tryptophan Metabolism: A link between the gut microbiome and cognitive function in obesity and related low-grade chronic inflammation disorders

Codi oficial: PI20/01090 Data inici: 01/01/2021 Data fi: 31/12/2023 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 171,820 €
Nutrició, Eumetabolisme i Salut

Señalización Auto-paracrina de la gamma-Sinucleína Derivada del Tejido Adiposo en Patología Relacionada con la Obesidad

Codi oficial: PI21/00074 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 145,200 €
Nutrició, Eumetabolisme i Salut

Interrelaciones entre las reservas de hierro, el metagenoma intestinal, los niveles de glucosa y diferentes dominios cognitivos: el papel de los microARN circulantes

Codi oficial: PI21/01361 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 304,920 €
Nutrició, Eumetabolisme i Salut

Dianas terapéuticas y biomarcadores de la medicina de precisión en MAFLD.

Codi oficial: PMP21/00072 Data inici: 01/01/2022 Data fi: 31/12/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 141,185 €
Nutrició, Eumetabolisme i Salut

Involvement of the gut microbiota-brain cross talk in the loss of eating control

Codi oficial: HR22-00737 Data inici: 01/10/2022 Data fi: 30/09/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUND. BANCARIA "LA CAIXA" Ajuda: 374,894.76 €

Publicacions

0

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions.

PHARMACOLOGICAL RESEARCH, 2023, 187, 106562-106562 dx.doi.org/10.1016/j.phrs.2022.106562

Rodríguez-Barrueco R, Latorre J, Devis-Jáuregui L, Lluch A, Bonifaci N, Llobet FJ, Olivan M, Coll-Iglesias L, Gassner K, Davis ML, Moreno-Navarrete JM, Castells-Nobau A, Plata-Peña L, Dalmau-Pastor M, Höring M, Liebisch G, Olkkonen VM, Arnoriaga-Rodríguez M, Ricart W, Fernández-Real JM, Silva JM, Ortega FJ, Llobet-Navas D

A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.

Advanced Science, 2022, 9 dx.doi.org/10.1002/advs.202104759

Latorre J, Ortega F, Oliveras-Cañellas N, Comas F, Lluch A, Gavaldà-Navarro A, Morón-Ros S, Ricart W, Villarroya F, Giralt M, Fernández-Real JM, Moreno-Navarrete JM

Specific adipose tissue Lbp gene knockdown prevents diet-induced body weight gain, impacting fat accretion-related gene and protein expression.

MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 27, 870-879 dx.doi.org/10.1016/j.omtn.2022.01.002
0

MicroRNAs signatures associated with vulnerability to food addiction in mice and humans.

JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 dx.doi.org/10.1172/JCI156281
0

Downregulation of peripheral lipopolysaccharide binding protein impacts on perigonadal adipose tissue only in female mice.

BIOMEDICINE & PHARMACOTHERAPY, 2022, 151, 113156-113156 dx.doi.org/10.1016/j.biopha.2022.113156
0

Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation.

MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 29, 599-613 dx.doi.org/10.1016/j.omtn.2022.08.003
0

Serum neuregulin 4 is negatively correlated with insulin sensitivity in humans and impairs mitochondrial respiration in HepG2 cells.

FRONTIERS IN PHYSIOLOGY, 2022, 13, 950791-950791 dx.doi.org/10.3389/fphys.2022.950791
0

A compound directed against S6K1 hampers fat mass expansion and mitigates diet-induced hepatosteatosis.

JCI Insight, 2022, 7 dx.doi.org/10.1172/jci.insight.150461
0

Lysozyme Gene Expression in 3T3-L1 Cells Sustains Expression of Adipogenic Genes and Adipocyte Differentiation.

Frontiers in Cell and Developmental Biology, 2022, 10, 914788-914788 dx.doi.org/10.3389/fcell.2022.914788
0

Adipose tissue cysteine dioxygenase type 1 is associated with an anti-inflammatory profile, impacting on systemic metabolic traits.

EBioMedicine, 2022, 85, 104302-104302 dx.doi.org/10.1016/j.ebiom.2022.104302

Formulari de contacte

Coneix l’IDIBGI!

 menu